Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 18;14(10):2488-91.
doi: 10.1021/ol300777p. Epub 2012 May 3.

Efficient synthesis of exo-N-carbamoyl nucleosides: application to the synthesis of phosphoramidate prodrugs

Jong Hyun Cho  1 , Steven J Coats, Raymond F Schinazi
Affiliations

Efficient synthesis of exo-N-carbamoyl nucleosides: application to the synthesis of phosphoramidate prodrugs

Jong Hyun Cho et al. Org Lett. .

Abstract

An efficient protection protocol for the 6-exo-amino group of purine nucleosides with various chloroformates was developed utilizing N-methylimidazole (NMI). The reaction of an exo-N(6)-group of adenosine analogue 1 with alkyl/and aryl chloroformates under optimized conditions provided the N(6)-carbamoyl adenosines (2a-j) in good to excellent yields. The reaction of N(6)-Cbz-protected nucleosides (5a-c) with phenyl phosphoryl chloride (7) using t-BuMgCl followed by catalytic hydrogenation afforded the corresponding phosphoramidate pronucleotides (8a-c) in excellent yield.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Benzyloxycarbonyl N-alkylimidazolium salts
Scheme 1
Scheme 1
Synthesis of purine phenyl phosphoramidates (8a-c)a aProduct was a diastereomeric mixture in which RP/SP or SP/RP ratio ranged from 1:1 to 1:1.5.
See this image and copyright information in PMC

References

    1. Wuts PGM, Greene TW. Green’s Protective Groups in Organic Synthesis. 4th edition John Wiley and Sons, Inc.; Hoboken, NJ: 2007.
    2. Kocienski PJ. Protecting Groups; Geoug Thieme Verlag Stuttgart. New York: 1994.
    1. Samano V, Miles RW, Robins MJ. J. Am. Chem. Soc. 1994;116:9331–9332.
    2. Miles RW, Samano V, Robins MJ. J. Am. Chem. Soc. 1995;117:5951–5957.
    3. Cui Z, Zhang L, Zhang B. Tetrahedron Lett. 2001;42:561–563.
    4. Nguyen-Trung NQ, Terenzi S, Scherer G, Strazewski P. Org. Lett. 2003;5:2603–2606. - PubMed
    5. Nowak I, Robins MJ. Org. Lett. 2003;5:3345–3348. - PubMed
    6. Zhong M, Nowak I, Robins MJ. J. Org. Chem. 2006;71:7773–7779. - PubMed
    7. Derudas M, Carta D, Brancale A, Vanpouille C, Lisco A, Margolis L, Balzarini J, McGuigan C. J. Med. Chem. 2009;52:5520–5530. - PMC - PubMed
    8. Arico JW, Calhoun AK, Salandria KJ, McLaughlin LW. Org. Lett. 2010;12:120–122. - PubMed

    1. For reviews: Bobeck DR, Coats SJ, Schinazi RF. Antivir. Ther. 2010;15:935–950. Erion MD, Hecker SJ. J. Med. Chem. 2008;51:2328–2345. Schultz C. Bioorg. Med. Chem. 2003;11:885–898. Mehellou Y, Balzarini J, McGuigan C. Chem. Med. Chem. 2009;4:1779–1791. Sofia MJ. Antivir. Chem. Chemother. 2011;22:23–49.

    1. Hotoda H, Saito R, Sekine M, Hata T. Tetrahedron. 1990;46:1181–1190.
    2. Strasser M, Ugi I. Acta Chem. Scand. 1993;47:125–130.
    1. Dey S, Garner PJ. Org. Chem. 2000;65:7697–7699. - PubMed
    2. Bazzanini R, Gouy M:H, Peyrottes S, Gosselin G, Perigaud C, Manfrendini S. Nucleosides, Nucleotides & Nucleic acids. 2005;24:1635–1649. - PubMed
    3. Wojciechowski F, Hudson RHE. J. Org. Chem. 2008;73:3807–3816. - PubMed
    4. Wang R:W, Gold B. Org. Lett. 2009;11:2465–2468. - PubMed

Publication types

MeSH terms